The initiative involves the establishment of a national research network to undertake important clinical studies into the safety and effectiveness of medicines for children. A consortium led by the University of Liverpool acts as the co-ordinating centre for the network, based at the Institute of Child Health at Alder Hey.
Many of the medicines used to treat children have been designed for adults and have not been properly tested on the young. Health professionals use their skill and judgement when prescribing medicines for the young but need better information from studies conducted with children to inform these decisions.
Andy Burnham, Minister of Delivery and Quality for the Department of Heath, who will formally launch the project tomorrow, said: “The Government is committed to making the UK the best place in the world for medical research and will invest over £750 million this year.
“Establishing the Medicines for Children Research Network will ensure that children benefit directly from the latest medical advances and treatments designed, developed and licensed specifically for their use.
"By bringing together the research expertise of the University of Liverpool and the world renowned children's care at Alder Hey, this initiative is a significant boost to Liverpool - putting it at the forefront of research of children's medicines in this country.”
Professor Sally C. Davies, Director General of R&D at the Department of Health said:
"This unique achievement will drive partnerships between the NHS and its young patients with top class researchers and with funding from the public, commercial and charitable sectors to meet the very specific needs of children across the entire range of health care and services. Our children are entitled to the same standards of treatment as adults and the MCRN will place this important issue at the heart of the national research effort."
The Medicines for Children Research Network (MCRN) is one of six topic-specific Research Networks which form a part of the UK Clinical Research Network, an initiative funded by the Department of Health to strengthen and facilitate clinical research across the UK with the aim of improving the quality, speed and coordination of research.
The network involves all types of health professionals, the pharmaceutical industry and most importantly, children and parents, who are helping to develop new medicines. A Young Person’s Advisory Group has been established which comprises 17 young people aged from nine to 18 who have been recruited through schools and youth organisations in Liverpool.
The group, which has named itself ‘Stand Up, Speak Up!’, will develop an understanding of the project and learn about the role of medicines in the promotion of good health.
They will work with project leaders on publicity material for children about the initiative and will act as ambassadors to encourage young people receiving medical care to participate in research projects.
Rosalind Smyth, Professor of Paediatric Medicine and director of the co-ordinating centre said: “This is the most important development towards improving children’s health that has happened during my professional career. We now have - in partnership with the pharmaceutical industry and other organisations that fund medical research - a real opportunity to provide medicines which will be of specific benefit to children.”
The MCRN will enable the development of a wide variety of drugs for children, including those for the prevention and treatment of diseases affecting newborns and children requiring intensive care. Researchers are developing treatments for a range of diseases in children such as meningitis, asthma, epilepsy and migraine.
The work of the MCRN is being undertaken by six Local Research Networks (LRNs), in England which will liaise with similar groups in the rest of the UK. These include more than 150 hospitals and Primary Care Trusts. University researchers are working jointly with the Trusts on drug development.
The Royal Liverpool Children's Hospital has been appointed as the host institution for the Cheshire, Merseyside & North Wales LRN, with Dr Matthew Peak and Dr Jo Blair as co-directors and Dr Charlie Orton as manager.
A £20 million grant will support the MCRN over five years and help to establish a world-class health service infrastructure to support clinical research and embed good clinical practice and quality in all clinical trials.
The MCRN has been developed in collaboration with the University of Liverpool; the Royal Liverpool Children’s Hospital; Imperial College, London; the Liverpool Women’s Hospital; the National Perinatal Epidemiology Unit at the University of Oxford and the National Children’s Bureau. It will be launched at Alder Hey on Thursday, 7 December.
Joanna Robotham | alfa
Investigators may unlock mystery of how staph cells dodge the body's immune system
22.09.2017 | Cedars-Sinai Medical Center
Monitoring the heart's mitochondria to predict cardiac arrest?
21.09.2017 | Boston Children's Hospital
Plants and algae use the enzyme Rubisco to fix carbon dioxide, removing it from the atmosphere and converting it into biomass. Algae have figured out a way to increase the efficiency of carbon fixation. They gather most of their Rubisco into a ball-shaped microcompartment called the pyrenoid, which they flood with a high local concentration of carbon dioxide. A team of scientists at Princeton University, the Carnegie Institution for Science, Stanford University and the Max Plank Institute of Biochemistry have unravelled the mysteries of how the pyrenoid is assembled. These insights can help to engineer crops that remove more carbon dioxide from the atmosphere while producing more food.
A warming planet
Our brains house extremely complex neuronal circuits, whose detailed structures are still largely unknown. This is especially true for the so-called cerebral cortex of mammals, where among other things vision, thoughts or spatial orientation are being computed. Here the rules by which nerve cells are connected to each other are only partly understood. A team of scientists around Moritz Helmstaedter at the Frankfiurt Max Planck Institute for Brain Research and Helene Schmidt (Humboldt University in Berlin) have now discovered a surprisingly precise nerve cell connectivity pattern in the part of the cerebral cortex that is responsible for orienting the individual animal or human in space.
The researchers report online in Nature (Schmidt et al., 2017. Axonal synapse sorting in medial entorhinal cortex, DOI: 10.1038/nature24005) that synapses in...
Whispering gallery mode (WGM) resonators are used to make tiny micro-lasers, sensors, switches, routers and other devices. These tiny structures rely on a...
Using ultrafast flashes of laser and x-ray radiation, scientists at the Max Planck Institute of Quantum Optics (Garching, Germany) took snapshots of the briefest electron motion inside a solid material to date. The electron motion lasted only 750 billionths of the billionth of a second before it fainted, setting a new record of human capability to capture ultrafast processes inside solids!
When x-rays shine onto solid materials or large molecules, an electron is pushed away from its original place near the nucleus of the atom, leaving a hole...
For the first time, physicists have successfully imaged spiral magnetic ordering in a multiferroic material. These materials are considered highly promising candidates for future data storage media. The researchers were able to prove their findings using unique quantum sensors that were developed at Basel University and that can analyze electromagnetic fields on the nanometer scale. The results – obtained by scientists from the University of Basel’s Department of Physics, the Swiss Nanoscience Institute, the University of Montpellier and several laboratories from University Paris-Saclay – were recently published in the journal Nature.
Multiferroics are materials that simultaneously react to electric and magnetic fields. These two properties are rarely found together, and their combined...
19.09.2017 | Event News
12.09.2017 | Event News
06.09.2017 | Event News
22.09.2017 | Life Sciences
22.09.2017 | Medical Engineering
22.09.2017 | Physics and Astronomy